Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma
NCT07479628
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Thymic Carcinoma
Interventions
OTHER:
adebrelimab plus chemoradiation
Sponsor
Shanghai Chest Hospital